Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Gene Expression Regulation by Lung Cancer Oncogenes
PubMed Full text in PMC Similar studies Analyze with GEO2R
Clinical Utility of Patient Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma
PubMed Similar studies Analyze with GEO2R
Effect of 35d and curcumin treatment on gene expression in GR6 cells
Gene Expression Patterns that Predict Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer Cell Lines and Human Lung Tumors
miRNA expression of gefitinib-resistant cell lines
Microarray analysis of SEMA5A downstream pathways on A549 cells
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling
PubMed Full text in PMC Similar studies SRA Run Selector
Expression data from PSAT1 overexpression in CL1-0 lung cancer cell line and PSAT1 knockdown in CL1-5 lung cancer cell line.
HTR3A is correlated with the unfavorable histology and promotes proliferation via ERK phosphorylation in lung adenocarcinoma
Quantitative in vivo analyses reveal a complex pharmacogenomic landscape in lung adenocarcinoma
Study the differential gene expression of different lung cancer EGFR mutants in NIH3T3 cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on